Variant report

Variant	nsv1013199
Chromosome Location	chr4:93395509-93511052
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:7)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:93434886..93436541-chr4:93486388..93487907,2	MCF-7	breast:
2	chr4:93404272..93405260-chr4:93422586..93423310,3	MCF-7	breast:
3	chr4:93384358..93386319-chr4:93419609..93421147,2	K562	blood:
4	chr4:93404272..93405260-chr4:93422586..93423310,3	MCF-7	breast:
5	chr4:93404272..93404961-chr4:93422474..93423086,2	MCF-7	breast:
6	chr4:93434886..93436541-chr4:93486388..93487907,2	MCF-7	breast:
7	chr4:93404272..93404961-chr4:93422474..93423086,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-9B6.1.1-4	chr4:93402672-93403529	ucscGeneNc_uc010ikw_1
2	lnc-RP11-9B6.1.1-4	chr4:93417224-93417476	ucscGeneNc_uc010ikw_1
3	lnc-RP11-9B6.1.1-4	chr4:93409417-93409530	ucscGeneNc_uc010ikw_1

No data

Extended variants
information (count: 4496 )
Associated
traits (count: 91 )

Variant overlapped rSNPs/rCNVs (count:4496 , 50 per page) page: 1 2 3 4 5 6 7 ... 90

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs192381500	chr4:93395563-93395564	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs566518592	chr4:93395567-93395568	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs139863232	chr4:93395570-93395571	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs561178403	chr4:93395577-93395578	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs78754206	chr4:93395588-93395589	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs146667618	chr4:93395594-93395595	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs537986342	chr4:93395596-93395597	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs11941374	chr4:93395615-93395616	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs565264721	chr4:93395711-93395712	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs577720411	chr4:93395755-93395756	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs140066992	chr4:93395836-93395837	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs554464663	chr4:93395850-93395851	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs183297084	chr4:93395905-93395906	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs150384524	chr4:93395969-93395970	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs549758332	chr4:93395975-93395976	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs112866965	chr4:93396096-93396097	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs375402495	chr4:93396101-93396102	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs398089016	chr4:93396119-93396120	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs138969723	chr4:93396120-93396121	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs13117942	chr4:93396146-93396147	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs145077568	chr4:93396231-93396232	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs76947771	chr4:93396240-93396241	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs71579560	chr4:93396265-93396266	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs200173478	chr4:93396277-93396278	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs71598448	chr4:93396279-93396280	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs373907960	chr4:93396281-93396282	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs368094121	chr4:93396282-93396283	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs371912621	chr4:93396283-93396284	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs545109814	chr4:93396307-93396308	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs201592354	chr4:93396339-93396340	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs564886620	chr4:93396343-93396344	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs72661916	chr4:93396344-93396345	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs546540622	chr4:93396345-93396346	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs369420693	chr4:93396404-93396405	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs560377434	chr4:93396510-93396511	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs191691575	chr4:93396576-93396577	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs549195349	chr4:93396609-93396610	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs547835942	chr4:93396634-93396635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs372507999	chr4:93396715-93396716	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs377005604	chr4:93396733-93396734	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs537898656	chr4:93396746-93396747	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs551524293	chr4:93396776-93396777	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs145948113	chr4:93396783-93396784	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs533766676	chr4:93396791-93396792	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs527564419	chr4:93396792-93396793	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs553516712	chr4:93396827-93396828	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs574274211	chr4:93396837-93396838	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs536586796	chr4:93396871-93396872	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs370964513	chr4:93396873-93396874	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs567052236	chr4:93396892-93396893	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:91)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	18414403	CNVD
primary effusion lymphomas	17116491	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Olfactory neuroblastoma	18408657	CNVD
small cell lung cancer	20016488	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
Colorectal cancer	20459617	CNVD
Acute monocytic leukemia	16498392	CNVD
Multiple myeloma	16616336	CNVD
Esophageal adenocarcinoma	18820669	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Parkinson disease	20877625	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	20164920	CNVD
Cancer	20164919	CNVD
Esophageal cancer	21851588	CNVD
Cancer	19907438	CNVD
Williams Syndrome	20824207	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22522925	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Bipolar disorder	19114987	CNVD
Autism	20841430	CNVD

Chromatin state (count:465 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:93376800-93396600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr4:93377000-93403400	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr4:93389200-93396600	Weak transcription	HUES6 Cell Line	embryonic stem cell
4	chr4:93391800-93396800	Enhancers	iPS-15b Cell Line	embryonic stem cell
5	chr4:93392600-93398400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
6	chr4:93392600-93399600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
7	chr4:93393000-93397400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
8	chr4:93394400-93396800	Weak transcription	HUES64 Cell Line	embryonic stem cell
9	chr4:93394400-93399400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
10	chr4:93394600-93395600	Weak transcription	HUES48 Cell Line	embryonic stem cell
11	chr4:93394600-93398000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
12	chr4:93394600-93398400	Weak transcription	H1 Cell Line	embryonic stem cell
13	chr4:93395400-93399800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
14	chr4:93395600-93395800	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr4:93395800-93396200	Weak transcription	HUES48 Cell Line	embryonic stem cell
16	chr4:93396200-93402200	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr4:93396600-93397400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr4:93396600-93400200	Enhancers	HUES6 Cell Line	embryonic stem cell
19	chr4:93396800-93397000	Enhancers	HUES64 Cell Line	embryonic stem cell
20	chr4:93396800-93398600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
21	chr4:93397000-93397400	Weak transcription	HUES64 Cell Line	embryonic stem cell
22	chr4:93397400-93398800	Enhancers	ES-I3 Cell Line	embryonic stem cell
23	chr4:93397400-93401400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
24	chr4:93397400-93402200	Enhancers	HUES64 Cell Line	embryonic stem cell
25	chr4:93398000-93398800	Enhancers	iPS-18 Cell Line	embryonic stem cell
26	chr4:93398400-93398800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
27	chr4:93398400-93398800	Enhancers	H1 Cell Line	embryonic stem cell
28	chr4:93398600-93402000	Enhancers	iPS-15b Cell Line	embryonic stem cell
29	chr4:93398800-93399200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
30	chr4:93398800-93399600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
31	chr4:93398800-93399600	Weak transcription	H1 Cell Line	embryonic stem cell
32	chr4:93398800-93401600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
33	chr4:93399200-93400400	Enhancers	iPS-18 Cell Line	embryonic stem cell
34	chr4:93399400-93400200	Enhancers	iPS-20b Cell Line	embryonic stem cell
35	chr4:93399600-93399800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
36	chr4:93399600-93400000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
37	chr4:93399600-93400200	Enhancers	H1 Cell Line	embryonic stem cell
38	chr4:93399800-93400000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
39	chr4:93399800-93400200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
40	chr4:93400000-93401600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
41	chr4:93400200-93400400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
42	chr4:93400200-93401400	Weak transcription	HUES6 Cell Line	embryonic stem cell
43	chr4:93400200-93401400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
44	chr4:93400200-93401600	Weak transcription	H1 Cell Line	embryonic stem cell
45	chr4:93400400-93401400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
46	chr4:93400400-93404400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
47	chr4:93401400-93402200	Enhancers	HUES6 Cell Line	embryonic stem cell
48	chr4:93401400-93402200	Enhancers	iPS-18 Cell Line	embryonic stem cell
49	chr4:93401400-93402200	Enhancers	iPS-20b Cell Line	embryonic stem cell
50	chr4:93401600-93402200	Enhancers	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links